These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9877014)

  • 1. An investigation of the effects of benzodiazepine receptor ligands and of scopolamine on conceptual priming.
    Bishop KI; Curran HV
    Psychopharmacology (Berl); 1998 Dec; 140(3):345-53. PubMed ID: 9877014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutral and emotional episodic memory: global impairment after lorazepam or scopolamine.
    Kamboj SK; Curran HV
    Psychopharmacology (Berl); 2006 Nov; 188(4):482-8. PubMed ID: 17047934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine.
    Curran HV; Pooviboonsuk P; Dalton JA; Lader MH
    Psychopharmacology (Berl); 1998 Jan; 135(1):27-36. PubMed ID: 9489931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of scopolamine, lorazepam, and glycopyrrolate on classical conditioning of the human eyeblink response.
    Bahro M; Schreurs BG; Sunderland T; Molchan SE
    Psychopharmacology (Berl); 1995 Dec; 122(4):395-400. PubMed ID: 8657840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scopolamine but not lorazepam modulates face repetition priming: a psychopharmacological fMRI study.
    Thiel CM; Henson RN; Dolan RJ
    Neuropsychopharmacology; 2002 Aug; 27(2):282-92. PubMed ID: 12093602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lorazepam and scopolamine: A single-dose comparison of effects on human memory and attentional processes.
    Mintzer MZ; Griffiths RR
    Exp Clin Psychopharmacol; 2003 Feb; 11(1):56-72. PubMed ID: 12622344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacological analysis of implicit and explicit memory: a study with lorazepam and the benzodiazepine antagonist flumazenil.
    Bishop KI; Curran HV
    Psychopharmacology (Berl); 1995 Sep; 121(2):267-78. PubMed ID: 8545533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes.
    Mintzer MZ; Griffiths RR
    Cogn Affect Behav Neurosci; 2007 Jun; 7(2):120-9. PubMed ID: 17672383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of gamma-aminobutyric acid-modulating drugs on working memory and brain function in patients with schizophrenia.
    Menzies L; Ooi C; Kamath S; Suckling J; McKenna P; Fletcher P; Bullmore E; Stephenson C
    Arch Gen Psychiatry; 2007 Feb; 64(2):156-67. PubMed ID: 17283283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological modulation of behavioral and neuronal correlates of repetition priming.
    Thiel CM; Henson RN; Morris JS; Friston KJ; Dolan RJ
    J Neurosci; 2001 Sep; 21(17):6846-52. PubMed ID: 11517272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lorazepam impairs both visual and auditory perceptual priming.
    Vidailhet P; Danion JM; Chemin C; Kazès M
    Psychopharmacology (Berl); 1999 Dec; 147(3):266-73. PubMed ID: 10639684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double dissociation between the effects of muscarinic antagonists and benzodiazepine receptor agonists on the acquisition and retention of passive avoidance.
    Cole BJ; Jones GH
    Psychopharmacology (Berl); 1995 Mar; 118(1):37-41. PubMed ID: 7597120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen replacement attenuates effects of scopolamine and lorazepam on memory acquisition and retention.
    Gibbs RB; Burke AM; Johnson DA
    Horm Behav; 1998 Oct; 34(2):112-25. PubMed ID: 9799622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scopolamine induces impairments in the recognition of human facial expressions of anger and disgust.
    Kamboj SK; Curran HV
    Psychopharmacology (Berl); 2006 May; 185(4):529-35. PubMed ID: 16555061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills.
    Duka T; Ott H; Rohloff A; Voet B
    Psychopharmacology (Berl); 1996 Feb; 123(4):361-73. PubMed ID: 8867876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lorazepam and oxazepam on perceptual and procedural memory functions.
    Martin J; Matthews A; Martin F; Kirkby KC; Alexander J; Daniels B
    Psychopharmacology (Berl); 2002 Nov; 164(3):262-7. PubMed ID: 12424549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of lorazepam and oxazepam on priming.
    Curran HV; Gorenstein C
    Int Clin Psychopharmacol; 1993; 8(1):37-42. PubMed ID: 8473719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of the effects of diazepam and lorazepam on perceptual priming and explicit memory.
    Legrand F; Vidailhet P; Danion JM; Grangé D; Giersch A; Van der Linden M; Imbs JL
    Psychopharmacology (Berl); 1995 Apr; 118(4):475-9. PubMed ID: 7568635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood.
    Curran HV; Schifano F; Lader M
    Psychopharmacology (Berl); 1991; 103(1):83-90. PubMed ID: 2006245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of the semicircular canals via the rotary chair as a means to test pharmacologic countermeasures for space motion sickness.
    Dornhoffer J; Chelonis JJ; Blake D
    Otol Neurotol; 2004 Sep; 25(5):740-5. PubMed ID: 15354005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.